Identifying tightly regulated and variably expressed networks by Differential Rank Conservation (DIRAC)

PLoS Computational Biology

Volumn 6, Issue 5, 2010, Pages 1-17

  Eddy, James A ^a,b   Hood, Leroy ^c   Price, Nathan D ^a,d   Geman, Donald ^e  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b United States of America   (United States)

^c INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATA HANDLING; GENE EXPRESSION;

BIOLOGICAL NETWORKS; BIOLOGICAL PATHWAYS; COMBINATORIAL INTERACTIONS; DISEASE PROCESS; GENE INTERACTIONS; MOLECULAR DATA; NETWORK BEHAVIORS; NETWORK PROFILES; OR-NETWORKS; QUANTITATIVE MEASURES;

CLASSIFICATION (OF INFORMATION);

ACCURACY; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL RANK CONSERVATION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC ANALYSIS; MATHEMATICAL MODEL; NEUROLOGIC DISEASE; ORDINATION ANALYSIS; PHENOTYPE; PROCESS DEVELOPMENT; PROSTATE CANCER; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; TREND STUDY; VALIDATION PROCESS; BIOLOGY; CLUSTER ANALYSIS; FACTUAL DATABASE; GENETICS; HUMAN; METHODOLOGY; NEOPLASM; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; NEOPLASMS; PHENOTYPE; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION;

EID: 77955484846     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1000792     Document Type: Article

References (38)

1. Hood L, Heath JR, Phelps ME, Lin B (2004) Systems biology and new technologies enable predictive and preventative medicine. Science 306: 640-643.
2. Chuang HY, Lee E, Liu YT, Lee D, Ideker T (2007) Network-based classification of breast cancer metastasis. Mol Syst Biol 3.
3. Land H, Parada LF, Weinberg RA (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596-602.
4. Lowe SW, Cepero E, Evan G (2004) Intrinsic tumour suppression. Nature 432: 307-315.
5. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
6. Nam D, Kim SY (2008) Gene-set approach for expression pattern analysis. Brief Bioinform 9: 189-197.
7. Kroemer G, Pouyssegur J (2008) Tumor Cell Metabolism: Cancer's Achilles' Heel. Cancer Cell 13: 472-482.
8. Hsu PP, Sabatini DM (2008) Cancer Cell Metabolism: Warburg and Beyond. Cell 134: 703-707.
9. Shaw RJ (2006) Glucose metabolism and cancer. Curr Opin Cell Biol 18: 598-608.
10. Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, et al. (2005) Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors. N Engl J Med 353: 2012-2024.
11. Shaw RJ, Cantley LC (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441: 424-430.
12. Karin M (2006) Nuclear factor-[kappa]B in cancer development and progression. Nature 441: 431-436.
13. Parsons DW, Jones S, Zhang X, Lin JC-H, Leary RJ, et al. (2008) An Integrated Genomic Analysis of Human Glioblastoma Multiforme. Science 321: 1807-1812.
14. McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, et al. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
15. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
16. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP (2007) GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 23: 3251.
17. Lee E, Chuang HY, Kim JW, Ideker T, Lee D (2008) Inferring Pathway Activity toward Precise Disease Classification. PLoS Comput Biol 4.
18. Auffray C (2007) Protein subnetwork markers improve prediction of cancer outcome. Mol Syst Biol 3.
19. Price ND, Trent J, El-Naggar AK, Cogdell D, Taylor E, et al. (2007) Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci U S A 104: 3414.
20. Weichselbaum RR, Ishwaran H, Yoon T, Nuyten DS, Baker SW, et al. (2008) An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci U S A 105: 18490-18495.
21. Raponi M, Lancet JE, Fan H, Dossey L, Lee G, et al. (2008) A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia. Blood 111: 2589-2596.
22. Tan AC, Naiman DQ, Xu L, Winslow RL, Geman D (2005) Simple decision rules for classifying human cancers from gene expression profiles. Bioinformatics 21: 3896-3904.
23. Geman D, d'Avignon C, Naiman DQ, Winslow RL (2004) Classifying gene expression profiles from pairwise mRNA comparisons. Stat Appl Genet Mol Biol 3: Article19.
24. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, et al. (2004) Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 22: 2790-2799.
25. Trapani JA, Smyth MJ (2002) Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2: 735-747.
26. Moreno CS, Matyunina L, Dickerson EB, Schubert N, Bowen NJ, et al. (2007) Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas. PLoS One 2: e441.
27. Yao Z, Jaeger JC, Ruzzo WL, Morale CZ, Emond M, et al. (2007) A Marfan syndrome gene expression phenotype in cultured skin fibroblasts. BMC Genomics 8: 319.
28. Kuriakose MA, Chen WT, He ZM, Sikora AG, Zhang P, et al. (2004) Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol Life Sci 61: 1372-1383.
29. Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, et al. (2004) A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5: 607-616.
30. Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, et al. (2006) Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 11: 965-978.
31. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
32. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, et al. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30: 41-47.
33. Tagnon HJ, Whitmore WF, Jr., Shulman NR (1952) Fibrinolysis in metastatic cancer of the prostate. Cancer 5: 9-12.
34. Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, et al. (2007) Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 7: 64.
35. Shimada K, Nakamura M, Ishida E, Konishi N (2006) Molecular roles of MAP kinases and FADD phosphorylation in prostate cancer. Histol Histopathol 21: 415-422.
36. Leek JT (2009) The tspair package for finding top scoring pair classifiers in R. Bioinformatics 25: 1203-1204.
37. Vapnik VN (2000) The nature of statistical learning theory. New York, NY: Springer Verlag.
38. Joachims T (1998) Making Large-Scale SVM Learning Practical. In: Schölkopf B, Burges CJC, Smola AJ, eds. Advances in Kernel Methods: Support Vector Learning. Cambridge, MA: MIT Press.